ArticleLeukemia2012

Residual normal stem cells can be detected in newly diagnosed chronic myeloid leukemia patients by a new flow cytometric approach and predict for optimal response to imatinib.

J J W M Janssen et al.PubMed ↗Publisher ↗

No numbers read from the abstract.